[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Europe Insulin Glargine Market Report 2016

November 2016 | 102 pages | ID: E003A1F4CC3EN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Insulin Glargine

Revenue, means the sales value of Insulin Glargine

This report studies sales (consumption) of Insulin Glargine in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
  • Sanofi-Aventis
  • Ganlee
  • DuPont
  • Eastman
  • HEC Pharm
Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Insulin Glargine in these countries, from 2011 to 2021 (forecast), like
  • Germany
  • France
  • UK
  • Russia
  • Italy
  • Spain
  • Benelux
Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
  • Type III
Split by application, this report focuses on sales, market share and growth rate of Insulin Glargine in each application, can be divided into
  • Application 1
  • Application 2
  • Application 3
Europe Insulin Glargine Market Report 2016

1 INSULIN GLARGINE OVERVIEW

1.1 Product Overview and Scope of Insulin Glargine
1.2 Classification of Insulin Glargine
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Insulin Glargine
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Insulin Glargine Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Insulin Glargine (2011-2021)
  1.5.1 Europe Insulin Glargine Sales and Growth Rate (2011-2021)
  1.5.2 Europe Insulin Glargine Revenue and Growth Rate (2011-2021)

2 EUROPE INSULIN GLARGINE BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Insulin Glargine Market Competition by Manufacturers
  2.1.1 Europe Insulin Glargine Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Insulin Glargine Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Insulin Glargine (Volume and Value) by Type
  2.2.1 Europe Insulin Glargine Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Insulin Glargine Revenue and Market Share by Type (2011-2016)
2.3 Europe Insulin Glargine (Volume and Value) by Countries
  2.3.1 Europe Insulin Glargine Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Insulin Glargine Revenue and Market Share by Countries (2011-2016)
2.4 Europe Insulin Glargine (Volume) by Application

3 GERMANY INSULIN GLARGINE (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Insulin Glargine Sales and Value (2011-2016)
  3.1.1 Germany Insulin Glargine Sales and Growth Rate (2011-2016)
  3.1.2 Germany Insulin Glargine Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Insulin Glargine Sales Price Trend (2011-2016)
3.2 Germany Insulin Glargine Sales and Market Share by Manufacturers
3.3 Germany Insulin Glargine Sales and Market Share by Type
3.4 Germany Insulin Glargine Sales and Market Share by Application

4 FRANCE INSULIN GLARGINE (VOLUME, VALUE AND SALES PRICE)

4.1 France Insulin Glargine Sales and Value (2011-2016)
  4.1.1 France Insulin Glargine Sales and Growth Rate (2011-2016)
  4.1.2 France Insulin Glargine Revenue and Growth Rate (2011-2016)
  4.1.4 France Insulin Glargine Sales Price Trend (2011-2016)
4.2 France Insulin Glargine Sales and Market Share by Manufacturers
4.3 France Insulin Glargine Sales and Market Share by Type
4.4 France Insulin Glargine Sales and Market Share by Application

5 UK INSULIN GLARGINE (VOLUME, VALUE AND SALES PRICE)

5.1 UK Insulin Glargine Sales and Value (2011-2016)
  5.1.1 UK Insulin Glargine Sales and Growth Rate (2011-2016)
  5.1.2 UK Insulin Glargine Revenue and Growth Rate (2011-2016)
  5.1.5 UK Insulin Glargine Sales Price Trend (2011-2016)
5.2 UK Insulin Glargine Sales and Market Share by Manufacturers
5.3 UK Insulin Glargine Sales and Market Share by Type
5.4 UK Insulin Glargine Sales and Market Share by Application

6 RUSSIA INSULIN GLARGINE (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Insulin Glargine Sales and Value (2011-2016)
  6.1.1 Russia Insulin Glargine Sales and Growth Rate (2011-2016)
  6.1.2 Russia Insulin Glargine Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Insulin Glargine Sales Price Trend (2011-2016)
6.2 Russia Insulin Glargine Sales and Market Share by Manufacturers
6.3 Russia Insulin Glargine Sales and Market Share by Type
6.4 Russia Insulin Glargine Sales and Market Share by Application

7 ITALY INSULIN GLARGINE (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Insulin Glargine Sales and Value (2011-2016)
  7.1.1 Italy Insulin Glargine Sales and Growth Rate (2011-2016)
  7.1.2 Italy Insulin Glargine Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Insulin Glargine Sales Price Trend (2011-2016)
7.2 Italy Insulin Glargine Sales and Market Share by Manufacturers
7.3 Italy Insulin Glargine Sales and Market Share by Type
7.4 Italy Insulin Glargine Sales and Market Share by Application

8 SPAIN INSULIN GLARGINE (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Insulin Glargine Sales and Value (2011-2016)
  8.1.1 Spain Insulin Glargine Sales and Growth Rate (2011-2016)
  8.1.2 Spain Insulin Glargine Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Insulin Glargine Sales Price Trend (2011-2016)
8.2 Spain Insulin Glargine Sales and Market Share by Manufacturers
8.3 Spain Insulin Glargine Sales and Market Share by Type
8.4 Spain Insulin Glargine Sales and Market Share by Application

9 BENELUX INSULIN GLARGINE (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Insulin Glargine Sales and Value (2011-2016)
  9.1.1 Benelux Insulin Glargine Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Insulin Glargine Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Insulin Glargine Sales Price Trend (2011-2016)
9.2 Benelux Insulin Glargine Sales and Market Share by Manufacturers
9.3 Benelux Insulin Glargine Sales and Market Share by Type
9.4 Benelux Insulin Glargine Sales and Market Share by Application

10 EUROPE INSULIN GLARGINE MANUFACTURERS ANALYSIS

10.1 Sanofi-Aventis
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Insulin Glargine Product Type, Application and Specification
    10.1.2.1 Type I
    10.1.2.2 Type II
  10.1.3 Sanofi-Aventis Insulin Glargine Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 Ganlee
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Insulin Glargine Product Type, Application and Specification
    10.2.2.1 Type I
    10.2.2.2 Type II
  10.2.3 Ganlee Insulin Glargine Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 DuPont
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Insulin Glargine Product Type, Application and Specification
    10.3.2.1 Type I
    10.3.2.2 Type II
  10.3.3 DuPont Insulin Glargine Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 Eastman
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Insulin Glargine Product Type, Application and Specification
    10.4.2.1 Type I
    10.4.2.2 Type II
  10.4.3 Eastman Insulin Glargine Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 HEC Pharm
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Insulin Glargine Product Type, Application and Specification
    10.5.2.1 Type I
    10.5.2.2 Type II
  10.5.3 HEC Pharm Insulin Glargine Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview

11 INSULIN GLARGINE MANUFACTURING COST ANALYSIS

11.1 Insulin Glargine Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Insulin Glargine

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Insulin Glargine Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Insulin Glargine Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE INSULIN GLARGINE MARKET FORECAST (2016-2021)

14.1 Germany Insulin Glargine Sales Forecast (2016-2021)
14.2 France Insulin Glargine Sales Forecast (2016-2021)
14.3 UK Insulin Glargine Sales Forecast (2016-2021)
14.4 Russia Insulin Glargine Sales Forecast (2016-2021)
14.5 Italy Insulin Glargine Sales Forecast (2016-2021)
14.6 Spain Insulin Glargine Sales Forecast (2016-2021)
14.7 Benelux Insulin Glargine Sales Forecast (2016-2021)
14.8 Europe Insulin Glargine Sales Forecast by Type (2016-2021)
14.9 Europe Insulin Glargine Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Insulin Glargine
Table Classification of Insulin Glargine
Figure Europe Sales Market Share of Insulin Glargine by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Insulin Glargine
Figure Europe Sales Market Share of Insulin Glargine by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Insulin Glargine Revenue and Growth Rate (2011-2021)
Figure France Insulin Glargine Revenue and Growth Rate (2011-2021)
Figure UK Insulin Glargine Revenue and Growth Rate (2011-2021)
Figure Russia Insulin Glargine Revenue and Growth Rate (2011-2021)
Figure Italy Insulin Glargine Revenue and Growth Rate (2011-2021)
Figure Spain Insulin Glargine Revenue and Growth Rate (2011-2021)
Figure Benelux Insulin Glargine Revenue and Growth Rate (2011-2021)
Figure Europe Insulin Glargine Sales and Growth Rate (2011-2021)
Figure Europe Insulin Glargine Revenue and Growth Rate (2011-2021)
Table Europe Insulin Glargine Sales of Key Manufacturers (2015 and 2016)
Table Europe Insulin Glargine Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Insulin Glargine Sales Share by Manufacturers
Figure 2016 Insulin Glargine Sales Share by Manufacturers
Table Europe Insulin Glargine Revenue by Manufacturers (2015 and 2016)
Table Europe Insulin Glargine Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Insulin Glargine Revenue Share by Manufacturers
Table 2016 Europe Insulin Glargine Revenue Share by Manufacturers
Table Europe Insulin Glargine Sales and Market Share by Type (2011-2016)
Table Europe Insulin Glargine Sales Share by Type (2011-2016)
Figure Sales Market Share of Insulin Glargine by Type (2011-2016)
Figure Europe Insulin Glargine Sales Growth Rate by Type (2011-2016)
Table Europe Insulin Glargine Revenue and Market Share by Type (2011-2016)
Table Europe Insulin Glargine Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Insulin Glargine by Type (2011-2016)
Figure Europe Insulin Glargine Revenue Growth Rate by Type (2011-2016)
Table Europe Insulin Glargine Sales and Market Share by Countries (2011-2016)
Table Europe Insulin Glargine Sales Share by Countries (2011-2016)
Figure Sales Market Share of Insulin Glargine by Countries (2011-2016)
Table Europe Insulin Glargine Revenue and Market Share by Countries (2011-2016)
Table Europe Insulin Glargine Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Insulin Glargine by Countries (2011-2016)
Table Europe Insulin Glargine Sales and Market Share by Application (2011-2016)
Table Europe Insulin Glargine Sales Share by Application (2011-2016)
Figure Sales Market Share of Insulin Glargine by Application (2011-2016)
Figure Germany Insulin Glargine Sales and Growth Rate (2011-2016)
Figure Germany Insulin Glargine Revenue and Growth Rate (2011-2016)
Figure Germany Insulin Glargine Sales Price Trend (2011-2016)
Table Germany Insulin Glargine Sales by Manufacturers (2015 and 2016)
Table Germany Insulin Glargine Market Share by Manufacturers (2015 and 2016)
Table Germany Insulin Glargine Sales by Type (2015 and 2016)
Table Germany Insulin Glargine Market Share by Type (2015 and 2016)
Table Germany Insulin Glargine Sales by Application (2015 and 2016)
Table Germany Insulin Glargine Market Share by Application (2015 and 2016)
Figure France Insulin Glargine Sales and Growth Rate (2011-2016)
Figure France Insulin Glargine Revenue and Growth Rate (2011-2016)
Figure France Insulin Glargine Sales Price Trend (2011-2016)
Table France Insulin Glargine Sales by Manufacturers (2015 and 2016)
Table France Insulin Glargine Market Share by Manufacturers (2015 and 2016)
Table France Insulin Glargine Sales by Type (2015 and 2016)
Table France Insulin Glargine Market Share by Type (2015 and 2016)
Table France Insulin Glargine Sales by Application (2015 and 2016)
Table France Insulin Glargine Market Share by Application (2015 and 2016)
Figure UK Insulin Glargine Sales and Growth Rate (2011-2016)
Figure UK Insulin Glargine Revenue and Growth Rate (2011-2016)
Figure UK Insulin Glargine Sales Price Trend (2011-2016)
Table UK Insulin Glargine Sales by Manufacturers (2015 and 2016)
Table UK Insulin Glargine Market Share by Manufacturers (2015 and 2016)
Table UK Insulin Glargine Sales by Type (2015 and 2016)
Table UK Insulin Glargine Market Share by Type (2015 and 2016)
Table UK Insulin Glargine Sales by Application (2015 and 2016)
Table UK Insulin Glargine Market Share by Application (2015 and 2016)
Figure Russia Insulin Glargine Sales and Growth Rate (2011-2016)
Figure Russia Insulin Glargine Revenue and Growth Rate (2011-2016)
Figure Russia Insulin Glargine Sales Price Trend (2011-2016)
Table Russia Insulin Glargine Sales by Manufacturers (2015 and 2016)
Table Russia Insulin Glargine Market Share by Manufacturers (2015 and 2016)
Table Russia Insulin Glargine Sales by Type (2015 and 2016)
Table Russia Insulin Glargine Market Share by Type (2015 and 2016)
Table Russia Insulin Glargine Sales by Application (2015 and 2016)
Table Russia Insulin Glargine Market Share by Application (2015 and 2016)
Figure Italy Insulin Glargine Sales and Growth Rate (2011-2016)
Figure Italy Insulin Glargine Revenue and Growth Rate (2011-2016)
Figure Italy Insulin Glargine Sales Price Trend (2011-2016)
Table Italy Insulin Glargine Sales by Manufacturers (2015 and 2016)
Table Italy Insulin Glargine Market Share by Manufacturers (2015 and 2016)
Table Italy Insulin Glargine Sales by Type (2015 and 2016)
Table Italy Insulin Glargine Market Share by Type (2015 and 2016)
Table Italy Insulin Glargine Sales by Application (2015 and 2016)
Table Italy Insulin Glargine Market Share by Application (2015 and 2016)
Figure Spain Insulin Glargine Sales and Growth Rate (2011-2016)
Figure Spain Insulin Glargine Revenue and Growth Rate (2011-2016)
Figure Spain Insulin Glargine Sales Price Trend (2011-2016)
Table Spain Insulin Glargine Sales by Manufacturers (2015 and 2016)
Table Spain Insulin Glargine Market Share by Manufacturers (2015 and 2016)
Table Spain Insulin Glargine Sales by Type (2015 and 2016)
Table Spain Insulin Glargine Market Share by Type (2015 and 2016)
Table Spain Insulin Glargine Sales by Application (2015 and 2016)
Table Spain Insulin Glargine Market Share by Application (2015 and 2016)
Figure Benelux Insulin Glargine Sales and Growth Rate (2011-2016)
Figure Benelux Insulin Glargine Revenue and Growth Rate (2011-2016)
Figure Benelux Insulin Glargine Sales Price Trend (2011-2016)
Table Benelux Insulin Glargine Sales by Manufacturers (2015 and 2016)
Table Benelux Insulin Glargine Market Share by Manufacturers (2015 and 2016)
Table Benelux Insulin Glargine Sales by Type (2015 and 2016)
Table Benelux Insulin Glargine Market Share by Type (2015 and 2016)
Table Benelux Insulin Glargine Sales by Application (2015 and 2016)
Table Benelux Insulin Glargine Market Share by Application (2015 and 2016)
Table Insulin Glargine Basic Information List
Table Sanofi-Aventis Insulin Glargine Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi-Aventis Insulin Glargine Sales Market Share (2011-2016)
Table Ganlee Basic Information List
Table Ganlee Insulin Glargine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ganlee Insulin Glargine Sales Market Share (2011-2016)
Table DuPont Basic Information List
Table DuPont Insulin Glargine Sales, Revenue, Price and Gross Margin (2011-2016)
Table DuPont Insulin Glargine Sales Market Share (2011-2016)
Table Eastman Basic Information List
Table Eastman Insulin Glargine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eastman Insulin Glargine Sales Market Share (2011-2016)
Table HEC Pharm Basic Information List
Table HEC Pharm Insulin Glargine Sales, Revenue, Price and Gross Margin (2011-2016)
Table HEC Pharm Insulin Glargine Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Insulin Glargine
Figure Manufacturing Process Analysis of Insulin Glargine
Figure Insulin Glargine Industrial Chain Analysis
Table Raw Materials Sources of Insulin Glargine Major Manufacturers in 2015
Table Major Buyers of Insulin Glargine
Table Distributors/Traders List
Figure Germany Insulin Glargine Sales and Growth Rate Forecast (2016-2021)
Figure Germany Insulin Glargine Revenue and Growth Rate Forecast (2016-2021)
Figure France Insulin Glargine Sales and Growth Rate Forecast (2016-2021)
Figure France Insulin Glargine Revenue and Growth Rate Forecast (2016-2021)
Figure UK Insulin Glargine Sales and Growth Rate Forecast (2016-2021)
Figure UK Insulin Glargine Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Insulin Glargine Sales and Growth Rate Forecast (2016-2021)
Figure Russia Insulin Glargine Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Insulin Glargine Sales and Growth Rate Forecast (2016-2021)
Figure Italy Insulin Glargine Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Insulin Glargine Sales and Growth Rate Forecast (2016-2021)
Figure Spain Insulin Glargine Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Insulin Glargine Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Insulin Glargine Revenue and Growth Rate Forecast (2016-2021)
Table Europe Insulin Glargine Sales Forecast by Type (2016-2021)
Table Europe Insulin Glargine Sales Forecast by Application (2016-2021 )


More Publications